Connection
David Raben to Histocompatibility Antigens Class I
This is a "connection" page, showing publications David Raben has written about Histocompatibility Antigens Class I.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.272 |
|
|
|
-
Westrich JA, Vermeer DW, Silva A, Bonney S, Berger JN, Cicchini L, Greer RO, Song JI, Raben D, Slansky JE, Lee JH, Spanos WC, Pyeon D. CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8+ T-cell responses by upregulating MHC-I expression. Oncogene. 2019 11; 38(46):7166-7180.
Score: 0.146
-
Cicchini L, Blumhagen RZ, Westrich JA, Myers ME, Warren CJ, Siska C, Raben D, Kechris KJ, Pyeon D. High-Risk Human Papillomavirus E7 Alters Host DNA Methylome and Represses HLA-E Expression in Human Keratinocytes. Sci Rep. 2017 06 16; 7(1):3633.
Score: 0.126